SCLC IS ‘ ON THE CUSP ’ OF BEING BETTER UNDERSTOOD , SAYS EXPERTO .
Mar 9, 2024
By Gregory Peter Kalemkerian, MD .
The Use Of Novel Agents Like TARLATAMAB May Be “ INTERESTING ” Among Patients With SMALL CELL LUNG CÁNCER In The Relapsed Setting, Says Gregory Peter Kalemkerian, MD .
*****************************
**********************
*************